Found: 50
Select item for more details and to access through your institution.
Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 170, n. 2, p. 451, doi. 10.1007/s11060-024-04803-2
- By:
- Publication type:
- Article
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2373, doi. 10.1007/s00432-021-03511-y
- By:
- Publication type:
- Article
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02145-6
- By:
- Publication type:
- Article
Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 18, p. 4474, doi. 10.3390/ijms20184474
- By:
- Publication type:
- Article
Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 8, p. 2462, doi. 10.3390/ijms19082462
- By:
- Publication type:
- Article
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 5, p. 1504, doi. 10.3390/ijms19051504
- By:
- Publication type:
- Article
Histologische und molekularpathologische Besonderheiten von Tumoren des peripheren Nervensystems.
- Published in:
- Die Pathologie, 2023, v. 44, n. 3, p. 197, doi. 10.1007/s00292-023-01198-1
- By:
- Publication type:
- Article
Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01195-y
- By:
- Publication type:
- Article
Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE Score.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1820, doi. 10.3390/jcm10091820
- By:
- Publication type:
- Article
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2031, doi. 10.3390/jcm8122031
- By:
- Publication type:
- Article
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1608, doi. 10.3390/jcm8101608
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.798811
- By:
- Publication type:
- Article
Single-shot bevacizumab for cerebral radiation injury.
- Published in:
- BMC Neurology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12883-021-02103-0
- By:
- Publication type:
- Article
Single-shot bevacizumab for cerebral radiation injury.
- Published in:
- BMC Neurology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12883-021-02103-0
- By:
- Publication type:
- Article
Single-shot bevacizumab for cerebral radiation injury.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127123
- By:
- Publication type:
- Article
Hypoxia Enhances the Antiglioma Cytotoxicity of B10, a Glycosylated Derivative of Betulinic Acid.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094921
- By:
- Publication type:
- Article
Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma.
- Published in:
- Journal of Neurochemistry, 2024, v. 168, n. 6, p. 1157, doi. 10.1111/jnc.16069
- By:
- Publication type:
- Article
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0583-4
- By:
- Publication type:
- Article
Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany.
- Published in:
- CNS Drugs, 2023, v. 37, n. 11, p. 993, doi. 10.1007/s40263-023-01049-w
- By:
- Publication type:
- Article
Clinical Outcome and Risk Factors of Red Blood Cell Transfusion in Patients Undergoing Elective Primary Meningioma Resection.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3601, doi. 10.3390/cancers13143601
- By:
- Publication type:
- Article
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3050, doi. 10.3390/cancers12103050
- By:
- Publication type:
- Article
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2144, doi. 10.3390/cancers12082144
- By:
- Publication type:
- Article
AMPK activation protects astrocytes from hypoxia-induced cell death.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 45, n. 5, p. 1385, doi. 10.3892/ijmm.2020.4528
- By:
- Publication type:
- Article
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma.
- Published in:
- Neuropathology & Applied Neurobiology, 2021, v. 47, n. 3, p. 379, doi. 10.1111/nan.12669
- By:
- Publication type:
- Article
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 7, p. 975, doi. 10.1093/neuonc/nox204
- By:
- Publication type:
- Article
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 6, p. 1509, doi. 10.1093/brain/awp093
- By:
- Publication type:
- Article
Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature.
- Published in:
- Epilepsia (Series 4), 2019, v. 60, n. 12, p. 2448, doi. 10.1111/epi.16382
- By:
- Publication type:
- Article
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CASP9 germline mutation in a family with multiple brain tumors.
- Published in:
- Brain Pathology, 2018, v. 28, n. 1, p. 94, doi. 10.1111/bpa.12471
- By:
- Publication type:
- Article
Serine-dependent redox homeostasis regulates glioblastoma cell survival.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad131
- By:
- Publication type:
- Article
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93663-1
- By:
- Publication type:
- Article
Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial.
- Published in:
- European Journal of Nutrition, 2022, v. 61, n. 1, p. 477, doi. 10.1007/s00394-021-02666-1
- By:
- Publication type:
- Article
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 2, p. 543, doi. 10.1111/ene.15140
- By:
- Publication type:
- Article
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A <sup>1</sup>H-Magnetic Resonance Spectroscopy Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168113
- By:
- Publication type:
- Article
Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients.
- Published in:
- Journal of Molecular Histology, 2021, v. 52, n. 2, p. 233, doi. 10.1007/s10735-020-09940-2
- By:
- Publication type:
- Article
Correction: Serine-dependent redox homeostasis regulates glioblastoma cell survival.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction: Serine-dependent redox homeostasis regulates glioblastoma cell survival.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review.
- Published in:
- Neurological Research & Practice, 2024, v. 6, n. 1, p. 1, doi. 10.1186/s42466-024-00314-7
- By:
- Publication type:
- Article
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
- Published in:
- Neurological Research & Practice, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42466-023-00282-4
- By:
- Publication type:
- Article
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 632, doi. 10.3390/cells13070632
- By:
- Publication type:
- Article
Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 3, p. 509, doi. 10.1007/s11060-023-04518-w
- By:
- Publication type:
- Article
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 1141, doi. 10.3892/ol.2017.6251
- By:
- Publication type:
- Article
PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 213, doi. 10.1093/neuonc/noab159
- By:
- Publication type:
- Article
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients.
- Published in:
- Current Oncology, 2022, v. 29, n. 4, p. 2225, doi. 10.3390/curroncol29040181
- By:
- Publication type:
- Article
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.
- Published in:
- Oncology Reports, 2017, v. 38, n. 6, p. 3291, doi. 10.3892/or.2017.6013
- By:
- Publication type:
- Article